New Study Suggests Weight Loss Drugs May Aid Addiction Treatment

Want the full story?
Read the complete article at KVIA
AI Summary
A recent study highlights the potential of GLP-1 medications, commonly used for weight loss, in combating addiction. With approximately 49 million Americans facing substance abuse disorders, this research offers hope. Analyzing health records of over 600,000 veterans with type 2 diabetes, the study found that those treated with GLP-1 drugs were significantly less likely to develop substance use disorders compared to those on other medications. Additionally, patients already diagnosed with substance use disorders experienced fewer severe outcomes, such as drug overdoses, when using GLP-1 treatments. While this study, published in the BMJ, shows promise, researchers emphasize the need for further investigation.
Key Details: • Study analyzed health records of over 600,000 veterans over three years. • GLP-1 medications may reduce risk of developing substance use disorders. • Patients on GLP-1 drugs had fewer severe outcomes related to addiction.